Prospective Pilot study of Quality of Life in... (2023 study) Skip to main content
Prospective Study Clin Transl Radiat Oncol 2023

Prospective Pilot study of Quality of Life in patients with severe late-radiation-toxicity treated by Low hyperbaric-oxigen-therapy

Vera-Rosas A, Aguiar D, Domínguez A, Cabrera-Vicente A, Martín-Barrientos P, Cabrera R, et al., Clin Transl Radiat Oncol, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers followed 48 adults with severe late side effects from radiation treatment who received daily sessions in a hyperbaric chamber at 1.45 ATA and asked them to rate their quality of life before, at the end of, and after treatment.

What They Found

This prospective pilot study of patients with grade 3 late radiation toxicity reported that median quality-of-life scores on the EORTC-QLQ-C30 questionnaire improved in all domains except cognitive function after hyperbaric oxygen therapy (HBOT) at 1.45 ATA, with a mean follow-up of 22.10 months (range 6 to 39). Treatment was 60 minutes daily at 100% oxygen, with 40 sessions prescribed over 8 weeks. Of the 48 patients enrolled, 37 (77%) completed the prescribed sessions, and 30 of those 37 completed follow-up questionnaires. The most common symptoms were pain (65%) and bleeding (54%), and anal fibrosis (9 of 37) and brain necrosis (7 of 37) were the most frequently treated conditions. The cognitive domain did not improve (p = 0.106).

What This Means for Canadian Patients

For people living with severe late radiation injury, this study reports that HBOT at 1.45 ATA was feasible and well tolerated, and that patients rated their physical function, daily activities and general health better over time. The study had no comparison group, so it cannot show that the treatment caused these changes. Anyone considering HBOT after radiotherapy should talk with their cancer care team about whether it fits their situation.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a small pilot study with no control group, about a quarter of the enrolled patients did not complete the prescribed treatment, and the results rely on patients' own questionnaire reports, so the findings cannot confirm that HBOT caused the improvements.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Prospective Study
Category Radiation Injury
Source Pubmed
PubMed ID 37066113
Year Published 2023
Journal Clin Transl Radiat Oncol

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology